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O B J E C T I V E S We aimed to evaluate whether pericardial fat has value in predicting the risk of
future adverse cardiovascular outcomes.
B A C KG ROUND Pericardial fat volume (PFV) and thoracic fat volume (TFV) can be routinely
measured from noncontrast computed tomography (NCT) performed for calculating coronary calcium
score (CCS) and may predict major adverse cardiac event (MACE) risk.
METHOD S From a registry of 2,751 asymptomatic patients without known cardiac artery disease
and 4-year follow-up for MACE (cardiac death, myocardial infarction, stroke, late revascularization) after
NCT, we compared 58 patients with MACE with 174 same-sex, event-free control subjects matched by
a propensity score to account for age, risk factors, and CCS. The TFV was automatically calculated, and
PFV was calculated with manual assistance in deﬁning the pericardial contour, within which fat voxels
were automatically identiﬁed. Independent relationships of PFV and TFV to MACE were evaluated using
conditional multivariable logistic regression.
R E S U L T S Patients experiencing MACE had higher mean PFV (101.8  49.2 cm3 vs. 84.9  37.7 cm3,
p  0.007) and TFV (204.7  90.3 cm3 vs. 177  80.3 cm3, p  0.029) and higher frequencies of PFV
125 cm3 (33% vs. 14%, p  0.002) and TFV 250 cm3 (31% vs. 17%, p  0.025). After adjustment for
Framingham risk score (FRS), CCS, and body mass index, PFV and TFV were signiﬁcantly associated with
MACE (odds ratio [OR]: 1.74, 95% conﬁdence interval [CI]: 1.03 to 2.95 for each doubling of PFV; OR: 1.78,
95% CI: 1.01 to 3.14 for TFV). The area under the curve from receiver-operator characteristic analyses
showed a trend of improved MACE prediction when PFV was added to FRS and CCS (0.73 vs. 0.68, p 0.058).
Addition of PFV, but not TFV, to FRS and CCS improved estimated speciﬁcity (0.72 vs. 0.66, p  0.008) and
overall accuracy (0.70 vs. 0.65, p  0.009) in predicting MACE.
CONC L U S I O N S Asymptomatic patients who experience MACE exhibit greater PFV on pre-MACE
NCT when they are compared with event-free control subjects with similar cardiovascular risk proﬁles.
Our preliminary ﬁndings suggest that PFV may help improve prediction of MACE. (J Am Coll Cardiol
Img 2010;3:352–60) © 2010 by the American College of Cardiology Foundation
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353he discovery that pericardial fat may lo-
cally affect coronary arterial health through
generation of inflammatory cytokines has
generated a great level of interest in using it
o predict adverse cardiovascular events (1). Peri-
ardial fat can be routinely detected by noncontrast
omputed tomography (NCT) performed for coro-
ary calcium scoring (CCS), potentially obviating
he need for dedicated diagnostic testing. On NCT,
ericardial fat volume (PFV) can be assessed by
irect measurement, which depends on reliable
etection of the thin pericardium. The PFV can
lso be assessed as a component of heart-level
horacic fat volume (TFV), whose boundaries are
ore robustly visualized, resulting in lower inter-
bserver variability (2,3).
To date, PFV detected on computed tomography
CT) has been linked to coronary artery disease
CAD) risk factors, significant prior cardiovascular
vents, coronary arterial calcium, severity of de-
ected CAD, and biochemical markers of systemic
nflammation (2,4–12). However, whether PFV
nd TFV are related to the occurrence of future
dverse cardiovascular outcomes has not been eval-
ated. A case-control study design, often used to
nitially assess the epidemiologic importance of
otentially novel disease markers and form the basis
or subsequent prospective research (13–15), is ad-
antageous for PFV and TFV because complete
uantification of both parameters in a large popu-
ation using currently available techniques would be
rohibitively time and labor intensive. We thus
onducted the following case-control study to eval-
ate whether PFV and TFV predict subsequent
ajor adverse cardiac events (MACE).
E T H O D S
atient population and imaging protocol. Our
tudy was a case-control analysis of 2,751 asymp-
omatic patients without known CAD enrolled in
he EISNER (Early Identification of Subclinical
therosclerosis Using Noninvasive Imaging Re-
earch) registry at Cedars-Sinai Medical Center,
os Angeles, California. Inclusion criteria for these
atients were age 45 to 80 years and exhibition of
ntermediate pre-test probability for CAD defined
y being: 1) men 55 years or women 65 years;
r 2) men 45 to 54 years or women 55 to 64 years
ith at least 1 traditional CAD risk factor. Exclu-
ion criteria were history of myocardial infarction,
oronary revascularization, cardiomyopathy, pe-
ipheral artery disease, angina, or stroke; history of vaving a prior coronary calcium scan or invasive
oronary angiogram; active pregnancy; clinical in-
tability; and significant medical comorbidity likely
o independently impact outcome during follow-up.
etween September 1998 and May 2005, these
atients underwent an index NCT to obtain a CCS
nd were prospectively followed for subsequent
ACE (including cardiac death, myocardial in-
arction, stroke, and late percutaneous or surgical
evascularization defined as occurring more than 6
onths after NCT). The occurrence of MACE was
onfirmed by direct contact between research staff
nd patient or next of kin, followed by review of
orresponding medical or death records by an in-
ependent cardiologist.
At 4 years of follow-up, 58 patients (46 men)
xperienced MACE, including 4 cardiac deaths, 13
onfatal myocardial infarctions, 8 strokes, 26 late
ercutaneous revascularizations, and 7 late surgical
evascularizations. We matched each MACE patient
o 3 same-sex, event-free control subjects by
sing a propensity score; the technique of
ropensity score–based matching has been
idely used to simultaneously control many
onfounders (16–18). An overall score was
rst calculated for each patient using a probit
odel that accounted for age, body mass
ndex (BMI), traditional risk factors (diabe-
es, hypertension, dyslipidemia, smoking
istory, and family CAD history), and
ogarithm-adjusted CCS (because distribu-
ion of CCS was non-normal). Each
ACE patient was then matched to 3
ame-sex control subjects with the closest
cores. A total of 232 patients (58 MACE patients
nd 174 control subjects) thus comprised the study
opulation. Framingham risk score (FRS) (19) was
alculated for all patients at the time of the index
CT. This study was conducted according to guide-
ines of the Cedars-Sinai Medical Center Institutional
eview Board. All patients provided written consent
or retrospective use of their data.
The NCT was acquired using an electron-beam
e-Speed, GE Healthcare, Milwaukee, Wisconsin)
r a 4-slice CT scanner (Somatom Volumezoom,
iemens Medical Solutions, Forchheim, Germany).
oth scanners were calibrated daily using air and
ater phantoms. Each scan extended from the
ortic arch to the diaphragm and was obtained
uring a single breath-hold. Scan parameters in-
luded heart rate– dependent electrocardiogram
riggering (typically 45% to 60% of the R-R inter-
A B B
A N D
CAD
CCS
FRS
MACE
event
NCT
tomog
PFV
TFVal), 35-cm field-of-view, and 512  512 mR E V I A T I O N S
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coronary artery disease
coronary calcium score
Framingham risk score
major adverse cardiac
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354ize. Tube voltage was 120 kVp with multislice
canning. Slice thickness was 3 mm for electron-
eam CT and 2.5 mm for multislice CT.
All CT images were initially reviewed by an
xpert reader, using semiautomatic, commercially
vailable software (ScImage, Los Altos, California)
o quantify coronary calcification. Total Agatston
CS was calculated as the sum of calcified plaque
cores of all coronary arteries (20). Acquired images
ere then transferred to a research workstation for
ericardial and thoracic fat quantification.
ericardial and thoracic fat quantiﬁcation. Definitions
f pericardial and thoracic fat were based on our
roup’s recent work (3): pericardial fat includes all
dipose tissue enclosed by the visceral pericardium,
ncluding all fat directly surrounding the coronary
rteries. Thoracic fat includes all adipose tissue
ithin the chest at the level of the heart, enclosed
y the posterior limit of the heart and above the
iaphragm, with the same cranial and caudal
oundaries defined for pericardial fat. Thoracic fat
ncludes pericardial fat.
Pericardial and thoracic fat quantification was
erformed by software (QFAT) developed at the
edars-Sinai Medical Center (3). The software can
e executed on standard Microsoft Windows (Mi-
rosoft Corp., Redmond, Washington) worksta-
ions and includes algorithms for automatic thoracic
avity and heart segmentation and quantification of
Figure 1. Steps in Semiautomatic PFV and TFV Quantiﬁcation
At each axial slice, the reader ﬁrst identiﬁes the pericardium (Panel
placed along the pericardial line, and a pericardial contour is then a
axial slices, the software algorithm detects and quantiﬁes all fat vox
(PFV). Fat voxels outside of the pericardial contour are also detected anhoracic fat, which we have already described (21).
mage data were processed as follows. First, the
pper slice limit, marked by bifurcation of the
ulmonary trunk, and lower slice limit, identified as
he last slice containing any portion of the heart,
ere manually chosen by an expert reader blinded
o patient status and clinical NCT interpretation.
ext, this reader defined 5 to 7 control points on
he pericardium in each transverse view. From these
ontrol points, piecewise cubic Catmull-Rom spline
unctions (22) were automatically generated to cre-
te a smooth, closed pericardial contour (Fig. 1).
he PFV and TFV were then automatically calcu-
ated (reported in cm3). Contiguous 3-dimensional
oxels between the Hounsfield unit limits of 190
o 30 were defined as fat voxels by default
23–26); these limits can be modified by the user if
eemed appropriate.
tatistical analysis. Distributions of CCS, PFV, and
FV as continuous variables were non-normal and
ere thus described as mean  SD after normal-
zation with logarithmic adjustment. Base-2 loga-
ithmic transformation was chosen because each
nit increase represented a more easily understand-
ble doubling of the variable in question; this
pproach has been adopted for CCS previously
27). Other continuous variables were described as
ean  SD. Univariate comparisons between pa-
ients experiencing MACE and control subjects
hite arrow). Five to 7 points (Panel 2, blue dots) are manually
matically generated (Panel 2). Once this task is completed for all
within the pericardial contour to generate pericardial fat volume1, w
uto
elsd added to PFV to generate thoracic fat volume (TFV) (Panel 3).
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355ere made using the Student t test or chi-square
est, as appropriate. Because individual covariate
ifferences between MACE patients and control
ubjects after matching by propensity score can still
ause confounding, conditional multivariable logis-
ic regression models were constructed to adjust for
hese differences while independent relationships
ere assessed among PFV, TFV, and MACE. This
pproach has been used previously (28,29). In the
onditional multivariable regression models, PFV
nd TFV were entered into separate analyses con-
aining age, CCS, and all traditional risk factors,
nd then into separate analyses containing BMI,
CS, and FRS. Model fit of the conditional logistic
egression analyses was checked using the likeli-
ood ratio test to evaluate whether addition of PFV
nd TFV yielded significant increases in deviance
hi-square, which would suggest improved predic-
ion of MACE. To further examine potential in-
remental value of PFV and TFV over established
isk prediction strategies, receiver-operator charac-
eristic (ROC) curves were constructed, and area
nder the curve (AUC) were compared. For all
OC analyses, FRS was a continuous variable;
inary thresholds of 400 for CCS, 125 cm3 for
FV, and 250 cm3 for TFV were selected (PFV and
FV thresholds were found from initial compari-
ons between patients developing MACE and con-
rol subjects). Differences in estimated sensitivity,
pecificity, and accuracy were compared using the
cNemar test. Associations and differences with p
0.05 were considered significant. All statistical
nalyses, including propensity score–based match-
ng as described at the beginning of the Methods
ection, were performed using STATA software
version 9, StataCorp LP, College Station, Texas).
E S U L T S
etween patients experiencing MACE and
atched control subjects, the mean absolute differ-
nce in propensity score was 0.035  0.025. Our
atching technique resulted in no significant dif-
erences in age, logarithm-adjusted CCS, and prev-
lence of traditional risk factors between compari-
on groups (univariable analysis results are shown in
able 1). Hypercholesterolemia (66% in MACE
roup, 64% in control group) and hypertension
81% in MACE group, 80% in control group) were
he most frequently found risk factors in both
roups. Mean FRS in the MACE group was higherhan that in the control group at the time of NCT
15  8 vs. 12  7, p  0.012), although both mean
cores predicted intermediate risk.
Detection of pericardial and thoracic fat and
uantification of PFV and TFV were successful in
ll cases. Analysis of the typical NCT required 5 to
0 min of user time to fully contour the pericar-
ium. The PFV and TFV were highly correlated to
ach other (r2  0.74).
Overall mean PFV was 89.1  41.4 cm3 (range
8.2 to 259.2 cm3), and mean TFV was 183.9 
3.6 cm3 (range 34.1 to 518.4 cm3). The MACE
roup had greater mean PFV and TFV than the
ontrol group (102  49 cm3 vs. 85  38 cm3, p 
.007, and 205  90 cm3 vs. 177  80 cm3, p 
.029, respectively). The MACE group had greater
requencies of PFV 125 cm3 (33% vs. 14%, p 
.002) and TFV250 cm3 (31% vs. 17%, p 0.025).
igures 2 and 3 each show representative examples of
ericardial and thoracic fat analysis in a MACE group
nd one of the corresponding control subjects.
Results from multivariable analyses are shown in
ables 2 and 3. In multivariable analyses adjusted
or age, CCS, and all traditional risk factors, PFV
as associated with MACE (OR: 1.91, 95% CI:
.14 to 3.19 per doubling of PFV), as was TFV
OR: 1.83, 95% CI: 1.08 to 3.09 per doubling of
FV). As expected from matching, none of the
ther variables showed a significant association. In
ultivariable analyses adjusted for BMI, CCS, and
RS, PFV (OR: 1.74, 95% CI: 1.03 to 2.95 per
oubling) and TFV (OR: 1.78, 95% CI: 1.01 to
.14 per doubling) remained significantly associated
ith MACE. In these analyses, FRS was a concur-
ent independent predictor of MACE when adjust-
Table 1. Characteristics of 58 Patients With MACE and 174 Matc
Event-Free Control Subjects
MACE
(Mean  SD or %)
Control Subjects
(Mean  SD or %)
Age, yrs 61 10 61 8
Men 79% 79%
Body mass index, Kg/m2 28.8 5.7 28.3 4.7
Diabetes 19% 17%
Hypertension 66% 64%
Hypercholesterolemia 81% 80%
Active smoking 12% 9%
Family CAD history 24% 21%
Log2(CCS)* 7.2 3.1 7.0 2.7
Framingham risk score 15 8 12 7
Matched variables are shown in italics. *Logarithmic transform of CCS was pe
adjust for its nonnormal distribution.
CAD  coronary artery disease; CCS  coronary calcium score; MACE  mahed
p Value
0.70
1.00
0.57
0.69
0.87
0.92
0.44
0.65
0.65
0.01
rformed to
jor adverse
cardiac events.
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356ng for PFV (OR: 1.10, 95% CI: 1.03 to 1.17) or
FV (OR: 1.10, 95% CI: 1.03 to 1.17). Addition of
FV and TFV to the model containing BMI, CCS,
nd FRS significantly increased the deviance chi-
quare statistic (15.3 vs. 10.8 for PFV, p  0.03;
4.9 vs. 10.8 for TFV, p  0.04), indicating
mproved model fit. Extrapericardial thoracic fat
olume (TFV  PFV) did not exhibit a significant
elationship to MACE when adjusting for BMI,
CS, and FRS (OR: 1.44, 95% CI: 0.91 to 2.28,
 0.12).
The ROC analysis using FRS and CCS 400
esulted in an AUC of 0.68; using FRS, CCS
400, and PFV 125 cm3 resulted in an AUC of
.73 (Fig. 4), a difference that trended toward
ignificance (p  0.058). The estimated sensitiv-
ty for predicting MACE when PFV 125 cm3
Figure 2. A Representative Example of PFV and TFV Quantiﬁcat
Within each panel, the top row shows standard coronal, axial, and
heart, and the bottom row shows the same images with superimpo
low). Top panel images are from a 58-year-old woman who underw
coronary artery disease 572 days after the noncontrast CT. Her PFV
matched 56-year-old event-free woman. Her PFV was 72 cm3 and T
score; other abbreviations as in Figure 1.as added to FRS and CCS 400 was not Tifferent than using FRS and CCS 400 only
0.65 vs. 0.61, p  0.48). However, the estimated
pecificity (0.72 vs. 0.66, p  0.009) and accuracy
0.70 vs. 0.65, p  0.009) improved. The ROC
nalysis using TFV 250 cm3 in place of PFV
id not show any significant difference (AUC
.68 vs. 0.68, p  0.7).
I S C U S S I O N
ur work is the first to directly evaluate the
elationship among PFV, TFV, and subsequent
dverse cardiovascular outcomes. In our case-
ontrol study, based on 4-year post-NCT
ollow-up in asymptomatic patients without es-
ablished CAD, we found that increased PFV
as independently related to MACE. Although
in Matched Patients With CCS of 0
ttal (left to right) computed tomography (CT) displays of the
detection of pericardial fat (red) and thoracic fat (red and yel-
coronary artery bypass graft surgery for symptomatic multivessel
187 cm3 and TFV was 315 cm3. Bottom panel images are from a
as 111 cm3. BMI  body mass index; CCS  coronary calciumion
sagi
sed
ent
was
FV wFV (which includes PFV) also exhibited an
i
t
w
m
t
fi
t
M
c
e
c
s
t
n
P
p
t
m
i
e
g
m
p
s
I
t
M
p
t
e
r
e
c
a
t
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 4 , 2 0 1 0
A P R I L 2 0 1 0 : 3 5 2 – 6 0
Cheng et al.
Pericardial Fat Burden and Adverse Outcomes
357ndependent relationship to MACE, a more de-
ailed, ROC-based evaluation showed that PFV
as the primarily responsible parameter. Further-
ore, we found no significant relationship be-
ween extrapericardial thoracic fat volume (de-
ned as TFV  PFV) and MACE. Therefore,
he association detected between TFV and
ACE was in all likelihood due to TFV’s close
orrelation to PFV.
Our findings provide an important insight into
xisting evidence linking PFV to markers of
ardiovascular risk. In particular, we demon-
trated that the potentially confounding associa-
ions among PFV, CAD risk factors, and CCS do
ot sufficiently explain the relationship between
FV and MACE (2,5,6,8 –10,12). By using a
ropensity score to account for the totality of
hese confounders and generate adequately
Figure 3. A Representative Example of PFV and TFV Quantiﬁcat
Within each panel, the top row shows standard coronal, axial, and
shows the same images with superimposed detection of pericardia
from a 73-year-old man with a CCS of 3,121 who suffered a nonfata
170 cm3 and TFV was 329 cm3. Bottom panel images are from a m
78 cm3 and TFV was 137 cm3. Abbreviations as in Figures 1 and 2.atched cohorts, we showed that PFV provided oncremental value for predicting MACE. How-
ver, despite matching MACE patients to control
roup with many features used to derive FRS, our
odels did not fully control for FRS, which remained
redictive of MACE. This finding highlights the
trong prognostic utility of FRS in our population.
mportantly, PFV still exhibited a significant associa-
ion with MACE after adjustments for FRS.
Independent prognostic value of PFV for
ACE may be a clinically relevant extension of
reviously described findings of elevated inflamma-
ion in pericardial fat depots. Mazurek et al. (1)
legantly showed that adipose tissue adjacent to the
ight coronary artery contained significantly higher
xpression of interleukin-1, interleukin-6, mono-
yte chemotactic protein, and tumor necrosis factor,
nd retained a greater number of inflammatory cells
han subcutaneous adipose tissue. A paracrine effect
in Matched Patients With Very High CCS
ttal (left to right) CT displays of the heart, and the bottom row
(red) and thoracic fat (red and yellow). Top panel images are
yocardial infarction 99 days after the noncontrast CT. His PFV was
ed 70-year-old event-free man with a CCS of 2,689. His PFV wasion
sagi
l fat
l m
atchf inflammatory cytokines from pericardial adipose
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358issue may promote atherogenesis and lead to ele-
ated risk of adverse coronary events, which made
p the majority of MACE in our population (46 of
8 events, if death and stroke are counted as
oncoronary events).
By definition, PFV and TFV are dependent
ariables. PFV has the advantage of being a more
hysiologically direct disease marker; however, it
as the disadvantage of dependency on clear demar-
ation of the thin pericardium for quantification,
aking it more challenging, time consuming, and
otentially less reproducible to measure than TFV
3). An example of this was seen in the work by
ing et al. (9), who measured TFV in a slab around
he origin of the left main coronary in part because
ericardium can be difficult to visualize in lean
ndividuals. Mahabadi et al. (11) showed that PFV,
ut not intrathoracic fat (equivalent to the extra-
ericardial thoracic fat volume in our study), was
elated to the burden of prior cardiovascular disease
fter adjusting for age, sex, BMI, and waist circum-
erence, suggesting that PFV may be a more specific
isease marker. However, Mahabadi et al. (11) did
ot examine the association between TFV and
ardiovascular disease burden. There is also evi-
ence suggesting that PFV and TFV may reflect
he risk of atherosclerotic disease in different re-
ions within the body. Rosito et al. (10) showed
Table 2. Results of Conditional Multivariable Regression
Analyses Adjusted for Age, Traditional Risk Factors, and CCS
Odds Ratio
(95% CI) p Value
Analysis with PFV
Age 1.00 (0.96–1.06) 0.72
Diabetes 1.49 (0.60–3.70) 0.39
Hypertension 1.01 (0.50–2.07) 0.97
Hypercholesterolemia 1.15 (0.51–2.57) 0.74
Active smoking 2.57 (0.76–8.70) 0.13
Family CAD history 1.28 (0.54–3.05) 0.57
Log2(CCS)* 1.07 (0.90–1.28) 0.43
Log2(PFV)* 1.91 (1.14–3.19) 0.01
Analysis with TFV
Age 1.01 (0.96–1.07) 0.60
Diabetes 1.38 (0.56–3.41) 0.48
Hypertension 0.96 (0.47–1.97) 0.92
Hypercholesterolemia 1.11 (0.50–2.47) 0.80
Active smoking 2.56 (0.76–8.65) 0.13
Family CAD history 1.26 (0.53–2.99) 0.60
Log2(CCS)* 1.06 (0.89–1.26) 0.53
Log2(TFV)* 1.83 (1.08–3.09) 0.02
*Logarithmic transform of CCS, PFV, and TFV were performed to adjust for
their non-normal distributions.
CI  conﬁdence intervals; PFV  pericardial fat volume; TFV  thoracic fattvolume; other abbreviations as in Table 1.hat although PFV was associated with coronary
alcification, TFV was associated with abdominal
ortic calcification. Our work is the first to demon-
trate that PFV is preferred over TFV when eval-
ating the risk of clinically important cardiovascular
utcomes.
We used an automated algorithm to quantify
FV (3,21) and a semiautomated approach, over a
ser-selected range of the heart, to quantify PFV.
ogistically, automatic quantification of TFV is
ignificantly less time consuming (typically 20 s)
nd more reproducible (3). However, results from
ur present study suggest that fully automated
lgorithms for measurement of PFV can add to
ardiovascular risk stratification and are needed for
tudying large patient cohorts.
tudy limitations. Our study had several limitations.
he population evaluated comprised primarily in-
ividuals at low risk, and this was reflected in the
odest number of adverse cardiovascular events. A
ase-control study design is more prone to con-
ounding than a cohort study design; however,
pplication of our semiquantitative technique to
easure whole-heart PFV in the entire cohort
ould have been prohibitively time and resource
ntensive, as noted. We used propensity score–
ased matching because simultaneous exact match-
ng of all variables was not possible; propensity
core–based matching may not be as powerful as
ndividual variable matching in controlling for po-
ential confounding. However, this design has been
reviously used with success (28,29). Although our
esults suggest additive utility of pericardial fat to
raditional MACE risk–stratifying tools, confirma-
Table 3. Results of Conditional Multivariable Regression
Analyses Adjusting for BMI, CCS, and FRS
Odds Ratio
(95% CI) p Value
Analysis with PFV
BMI 0.98 (0.92–1.06) 0.661
Log2(CCS)* 1.06 (0.90–1.25) 0.473
FRS 1.10 (1.03–1.17) 0.003
Log2(PFV)* 1.74 (1.03–2.95) 0.038
Analysis with TFV
BMI 0.97 (0.90–1.05) 0.484
Log2(CCS)* 1.05 (0.89–1.24) 0.548
FRS 1.10 (1.03–1.17) 0.003
Log2(TFV)* 1.78 (1.01–3.14) 0.047
*Logarithmic transform of CCS, PFV, and TFV were performed to adjust for
their non-normal distributions.
BMI  body mass index; FRS  Framingham risk score; other abbreviations
as in Tables 1 and 2.ion through longitudinal whole-cohort evaluation
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359s needed. In addition, because individual risk
actors were matched, we did not match for FRS to
void redundancy.
O N C L U S I O N S
symptomatic patients who experienced MACE
xhibited greater PFV on pre-MACE NCT than
atched event-free control subjects with similar
ardiovascular risk profiles. Our preliminary find-
ngs suggest that increased pericardial fat may help
redict adverse cardiovascular outcomes.
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